Ben Youssef NAIMI - BIOBANQUES 18 mai 2016
Biobanking National Infrastructure Meeting
Quality matters: Improving the quality of biological resources
Session 3: Quality control in Genomics / Session 3A
Ben Youssef NAIMI
AnyGenes molecular platform for biomarkers profiling.
Abstract: AnyGenes® is an R&D driven Small Medium Enterprise (SME), established in 2007 and located in TENON Hospital in Paris. It specializes in signaling pathways profiling, biomarkers discovery and validation. Our databases of over thousands of validated factors are now available and fast growing. They represent signaling pathways of different cellular processes (cell cycle, apoptosis, autophagy, drug resistance, drug metabolism...), and for severe disease (cancer, neurodegenerative disease, autoimmune diseases...), specifically designed to be analyzed by high-throughput technology (HTqPCR) and dedicated home designed software data analysis. AnyGenes® broad range of technologies are used for disease biomarkers (e.g. prostate cancer, breast cancer, neurodegenerative diseases...) and for drug development including in vitro drug screening, mechanism of action, search of biomarkers and data analysis for patient stratification. Our goal is to develop innovative clinical tests for selecting patients most likely to respond to a developed targeted therapy. AnyGenes® has its own i) laboratories with well equipped platform and validated technology, ii) data-mining platform to design specific pathways, data analysis and software development.
WEDNESDAY MAY 18, 2016